epirubicin has been researched along with Hepatic Veno Occlusive Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Kraker, J; Dijkgraaf, MG; Heij, H; Jagt, CT; Taminiau, JA; Ten Kate, F; Verschuur, AC; Zuckermann, M | 1 |
| Sahoo, RK; Sharma, A | 1 |
2 other study(ies) available for epirubicin and Hepatic Veno Occlusive Disease
| Article | Year |
|---|---|
Veno-occlusive disease as a complication of preoperative chemotherapy for Wilms tumor: A clinico-pathological analysis.
Topics: Alanine Transaminase; Antineoplastic Combined Chemotherapy Protocols; Aspartate Aminotransferases; Chemotherapy, Adjuvant; Child; Child, Preschool; Dactinomycin; Doxorubicin; Epirubicin; Female; Hepatic Veno-Occlusive Disease; Humans; Incidence; Infant; Kidney Neoplasms; Liver; Male; Neoadjuvant Therapy; Nephrectomy; Postoperative Complications; Retrospective Studies; Ultrasonography; Wilms Tumor | 2009 |
Sinusoidal obstruction syndrome during induction therapy for acute lymphoblastic leukemia managed with N-acetyl Cysteine.
Topics: Acetylcysteine; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Epirubicin; Female; Fibrinolytic Agents; Hepatic Veno-Occlusive Disease; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sepsis; Young Adult | 2011 |